HONG KONG, Feb. 20, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) today announced the company has successfully enrolled the first patient in its multicenter, randomized, double-blind Phase III clinical trial of ivonescimab in […]
Tag: Clinical Trials & Medical Discoveries
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2025 /PRNewswire/ — Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced the activation of its first clinical trial site […]
EMA validates indication extension application for Aspaveli® for treatment of C3G and primary IC-MPGN
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ — Sobi® and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli® (pegcetacoplan) for the treatment of C3 glomerulopathy (C3G) and primary immune […]
Phanes Therapeutics Announces First Patient Dosed in Clinical Study of Peluntamig (PT217) in Combination with Chemotherapy
SAN DIEGO, Feb. 19, 2025 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in […]
Berlin Heals Holding AG réussit à lever plus de 7 millions de francs suisses pour lancer les premières études sur de nouvelles approches moins invasives USA – Français USA – English USA – English USA – español
ZUG, Suisse, 19 février 2025 /PRNewswire/ — Berlin Heals Holding AG, une start-up de technologie médicale en phase avancée de développement, a mis au point une méthode et un produit révolutionnaires pour le traitement de l’insuffisance […]
